share_log
Breakings ·  Jan 22 19:20

Johnson & Johnson: Fourth quarter pharmaceutical revenue was 14.33 billion USD, estimated at 14.21 billion USD. Fourth quarter adjusted EPS was 2.04 USD, estimated at 1.99 USD. Sales are expected to reach 89.2 billion to 90 billion USD in 2025.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment